who make tirzepatide FDA approves new weight loss drug with remarkable track record Tirzepatide | C225H348N48O68 | CID

Only Novo Nordisk manufactures FDA-approved semaglutide medicines, like Ozempic

GIP is the main incretin hormone in healthy people, causative of most the incretin effects, but the insulin response after GIP secretion in type 2 diabetes mellitus (T2DM) is strongly reduced

The close timing of these symptoms onset with the initiation of semaglutide, and their significant improvement within 11 days of discontinuing the medication, underscores a potential causal relationship between semaglutide and the rapid onset of depressive symptoms

Read More KEY INSIGHTS In 2026, Novo Nordisks patent on semaglutide will expire in several countries, including India and China

In addition, the TGA strictly regulates advertisements for prescription-only medication, including both approved and unapproved peptide products. The maximum penalty for unlawfully supplying peptides is a fine of $2,200 and/or imprisonment for 2 years